Skip to main navigation
Now accepting applications for SPARK™ - Albireo’s Grants in Rare Liver Disease program.
Learn more
.
Clinical Trials
Partnerships
Media
Careers
Contact
Science & Medicine
Scientific Focus
Pipeline
Medicines
Patients & Families
Diseases & Conditions
Patient Resources
Clinical Trials
Access to Bylvay
TM
(odevixibat)
Responsibility
Access
Funding Requests
Disclosures
About Us
Leadership
Board of Directors
Investors
Press Releases
Events & Presentations
2022 Annual Meeting
Corporate Governance & ESG
Stock Information
Financials & Filings
Analyst Coverage
Contact Us
+
Science & Medicine
Scientific Focus
Pipeline
Medicines
Patients & Families
Diseases & Conditions
Clinical Trials
Patient Resources
Managed Access
Responsibility
Access
Funding Requests
Disclosures
About Us
Leadership
Board of Directors
Partnerships
Investors
Press Releases
Events & Presentations
2021 Annual Meeting
Corporate Governance
Stock Information
Financials & Filings
Analyst Coverage
Contact Us
Careers
Media
Contact
Event Details
Albireo Provides First Quarter 2022 Business Update
May 16, 2022 at 4:30 PM EDT
Listen to webcast
Email Alerts
RSS
Print
